Lung Non-Small Cell Carcinoma Clinical Trials

29 studies are recruiting for lung non-small cell carcinoma in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Los Angeles, California 8 Ann Arbor, Michigan 6 Chicago, Illinois 6 Columbus, Ohio 6 Seattle, Washington 6 Ashland, Wisconsin 5 Billings, Montana 5 Bloomington, Illinois 5 Bozeman, Montana 5 Canton, Illinois 5 Carthage, Illinois 5 Coeur d'Alene, Idaho 5 Collierville, Tennessee 5 Decatur, Illinois 5 Deer River, Minnesota 5 Duarte, California 5 Duluth, Minnesota 5 Eureka, Illinois 5 Galesburg, Illinois 5 Great Falls, Montana 5 Hibbing, Minnesota 5 Jonesboro, Arkansas 5 Kewanee, Illinois 5 Macomb, Illinois 5 Memphis, Tennessee 5 Missoula, Montana 5 O'Fallon, Illinois 5 Oklahoma City, Oklahoma 5 Ottawa, Illinois 5 Pekin, Illinois 5 Peoria, Illinois 5 Peru, Illinois 5 Post Falls, Idaho 5 Princeton, Illinois 5 Rochester, Minnesota 5 Sandpoint, Idaho 5 Sandstone, Minnesota 5 Virginia, Minnesota 5 Washington, Illinois 5 ‘Aiea, Hawaii 4 ‘Ewa Beach, Hawaii 4 Ames, Iowa 4 Anaconda, Montana 4 Atlanta, Georgia 4 Battle Creek, Michigan 4 Boise, Idaho 4 Brainerd, Minnesota 4 Brighton, Michigan 4 Canton, Michigan 4 Cape Girardeau, Missouri 4 Chelsea, Michigan 4 Columbus, Mississippi 4 Danville, Illinois 4 Edmonds, Washington 4 Effingham, Illinois 4 Fargo, North Dakota 4 Flint, Michigan 4 Fort Dodge, Iowa 4 Fremont, California 4 Grand Rapids, Michigan 4

Studies, page 2

  1. Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

    This early phase 1 trial will investigate the combination of low-dose interleukin-2 (IL-2) and pembrolizumab in patients with previously untreated stage IV non-small cell lung cancer (NSCLC). Preclinical data demonstrate reinvigoration of exhausted T cells into an effector-like phenotype with impro…

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Emory University/Winship Cancer Institute, Atlanta, Georgia
    Run by
    Emory University

    See if you can join NCT05493566 on ClinicalTrials.gov

  2. The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

    This clinical trial compares the effect of pulmonary vein-first surgical technique to pulmonary artery-first surgical technique in decreasing circulating tumor cell deoxyribonucleic acid (ctDNA) in patients with stage I-III non-small cell lung cancer. Pulmonary vein first and pulmonary artery first…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Abington Memorial Hospital, Abington, Pennsylvania
    Locations
    4 in total
    Run by
    Thomas Jefferson University

    See if you can join NCT05502523 on ClinicalTrials.gov

  3. Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

    This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Roswell Park Cancer Institute, Buffalo, New York
    Run by
    Roswell Park Cancer Institute

    See if you can join NCT05292521 on ClinicalTrials.gov

  4. Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

    This phase I/II trial tests the safety and efficacy of split-course adaptive radiation therapy in combination with immunotherapy with or without chemotherapy for the treatment of patients with stage IV lung cancer or lung cancer that that has spread to nearby tissue or lymph nodes (locally advanced…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
    Run by
    Vanderbilt-Ingram Cancer Center

    See if you can join NCT05501665 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.